Healthcare Distribution Alliance – Patients Move Us.
Share Print


HDA Statement on New York Opioid Stewardship Act Ruling

December 19, 2018

ARLINGTON, Va. — Following U.S. District Court Judge Katherine Polk Failla’s ruling today that New York’s Opioid Stewardship Act is unconstitutional, the Healthcare Distribution Alliance (HDA) issued the following statement.

“We are grateful for the Court’s determination that the Opioid Stewardship Act is unconstitutional. The Act’s unconstitutional surcharge and cost-pass-through prohibition are the wrong way to address the opioid epidemic and would have resulted in significant disruption to patients and the healthcare system.

“HDA supports a variety of meaningful policy changes to address opioid abuse and misuse. These include improving communication and coordination between distributors and regulatory agencies as well as educating patients, providers, and pharmacists on the risks and responsibilities associated with opioids.”


The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.


© 2020 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365